| Literature DB >> 31575005 |
Patrícia Diogo1,2, M Amparo F Faustino3, M Graça P M S Neves4, Paulo J Palma5,6, Isabel P Baptista7,8, Teresa Gonçalves9,10, João Miguel Santos11,12.
Abstract
Apical periodontitis is a biofilm-mediated disease; therefore, an antimicrobial approach is essential to cure or prevent its development. In the quest for efficient strategies to achieve this objective, antimicrobial photodynamic therapy (aPDT) has emerged as an alternative to classical endodontic irrigation solutions and antibiotics. The aim of the present critical review is to summarize the available evidence on photosensitizers (PSs) which has been confirmed in numerous studies from diverse areas combined with several antimicrobial strategies, as well as emerging options in order to optimize their properties and effects that might be translational and useful in the near future in basic endodontic research. Published data notably support the need for continuing the search for an ideal endodontic photosensitizer, that is, one which acts as an excellent antimicrobial agent without causing toxicity to the human host cells or presenting the risk of tooth discoloration. The current literature on experimental studies mainly relies on assessment of mixed disinfection protocols, combining approaches which are already available with aPDT as an adjunct therapy. In this review, several approaches concerning aPDT efficiency are appraised, such as the use of bacteriophages, biopolymers, drug and light delivery systems, efflux pump inhibitors, negative pressure systems, and peptides. The authors also analyzed their combination with other approaches for aPDT improvement, such as sonodynamic therapy. All of the aforementioned techniques have already been tested, and we highlight the biological challenges of each formulation, predicting that the collected information may encourage the development of other effective photoactive materials, in addition to being useful in endodontic basic research. Moreover, special attention is dedicated to studies on detailed conditions, aPDT features with a focus on PS enhancer strategies, and the respective final antimicrobial outcomes. From all the mentioned approaches, the two which are most widely discussed and which show the most promising outcomes for endodontic purposes are drug delivery systems (with strong development in nanoparticles) and PS solubilizers.Entities:
Keywords: antimicrobial photodynamic therapy; biofilms; endodontic therapy; root canal disinfection
Year: 2019 PMID: 31575005 PMCID: PMC6963755 DOI: 10.3390/jfb10040044
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Figure 1Antimicrobial photodynamic therapy (aPDT) photochemical mechanisms and its reactions products versus microorganisms’ cell wall. Teeth and microorganism cell-wall illustration sizes and scales are not respected. PS: photosensitizer; ROS: reactive oxygen species; *: excited state.
Figure 2Structures of the PSs in Tables 1–6.
Bacteriophage and drug delivery systems characteristics used with focus on aPDT improvement.
| System | Approach | PS/λ(nm) | Microorganism(s) | |
|---|---|---|---|---|
|
| Supramacromolecule of DNA and Coated Proteins |
| ||
|
| Cellulose acetate dissolved in acetone | MRSA, | ||
| Cellulosic fabric of β(1,4)- |
| |||
| Poly-β(1,4)- |
| |||
| Foam formulations constituted by the gel-forming polymer sodium alginate, the gelling agent calcium carbonate, the plasticizers sorbitol and glycerol, the foaming agent hydroxypropylMethylcellulose, and as PS solubilizer agents β- and γ-cyclodextrins and polyethylene glycol 400 |
| Infected wounds | ||
| Water and salt (sodium chloride). Acid–EW and Alkaline–EW |
|
| ||
| Cross-linked poly (vinyl alcohol) (PVA)–borate complexes | MRSA | |||
|
|
| |||
|
|
| MRSA | ||
|
| MRSA | |||
|
|
| |||
|
| Methicillin-susceptible | |||
LEGEND—PPA: pheophorbide a; TBO: toluidine blue-O; RB: rose bengal; TMAP4+: 5,10,15,20-tetrakis(4-N,N,N-trimethylammoniumphenyl)porphyrin; ZnTMAP4+: zinc(II) complex of TMAP4+; MB: methylene blue; TMPyP: 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-tosylate; MRSA: methicillin-resistant strain of Staphylococcus aureus; mTHPC: 5,10,15,20-Tetrakis(m-hydroxyphenyl)chlorin; TDPyP: 5-(1-dodecanoylpyridinium-4yl)-10,15,20-triphenylporphyrin; Hp: hematoporphyrin dihydrochloride; ClAlPc: chloro-aluminumphthalocyanine.
Figure 3Structures of some of drug delivery systems in Tables 1–3.
Metal–organic frameworks (MOFs), the nanoparticle systems most used to improve aPDT efficacy to date, and their features.
| System | Approach | PS/λ(nm) | Microorganism(s) | ||
|---|---|---|---|---|---|
|
| Metal ions coordinated to organic ligands with one-, two-, or three-dimensional structure | ICG |
| ||
|
| Carbon | SWCNTs | H2TriMAPP |
| |
| MWCNTs | PPIX | ||||
| Nano-graphene oxide (NGO) | ICG |
| |||
| Fullerenes (C60, C70, and C84) in a closed sphere of carbon molecules | BF4-6 | ||||
| LC16 | |||||
| Poly( | MB |
| |||
| Colloidal gold particles complexed with poly lactic- | MB | ||||
| Platinum hexagonal nanoparticles | ClGaTCPP |
| |||
| Pure SiO2 nanoparticles synthesized by hydrolysis of tetraethyl orthosilicate in reverse microemulsion | RB | MRSA, | |||
| Silver nitrate was dissolved in | TPP |
| |||
| Hematite (α-Fe2O3), maghemite (γ-Fe2O3), and magnetite (Fe3O4) |
| ||||
LEGEND—SWCNTs: single-walled carbon nanotubes; MWCNTs: multi-walled carbon nanotubes; TMAPP: 5,10,15-triphenyl-20-(4-aminophenyl)porphyrin; PPIX: protoporphyrin IX; ICG: indocyanine green; BF1–3: functionalized C60 with one, two, or three polar diserinol groups; and BF4–6: functionalized C60 with one, two, or three quaternary pyrrolidinium groups; LC16: fullerene-functionalized C60; ClGGaTCPP: 5,10,15,20-tetrakis-(4-carboxyphenyl)porphyrinate gallium(III) chloride; TPP: 5,10,15,20-tetraphenylporphyrin.
Efflux pump inhibitors (EPIs), light source, and negative pressure system features presumed to improve aPDT efficacy.
| System | Approach | PS/λ(nm) | Microorganism(s) | ||
|---|---|---|---|---|---|
|
|
| Deficient mutants of Gram + |
| ||
|
| Deficient mutants of Gram − |
| |||
|
|
| ||||
|
|
| ||||
|
| Optical fiber inside the root canal at the established working length (WL) with spiral movements for apical to cervical | ||||
| Optical diffuser fiber within the canal |
| ||||
| Experimental model with human premolars and molars in an acrylic resin bloc simulating the optical properties of a porcine jaw |
| ||||
| EndoVac® system (Discus Dental, Culver City, CA, USA) |
| ||||
LEGEND—TBO: toluidine blue-O; DMMB: 1,9-dimethylmethylene blue; pL–ce6: poly-l-lysine–chlorin e6 conjugate; TMPyPb: 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-(p-toluenesulfonate).
Peptide approaches used to improve aPDT efficacy and their features.
| Systems | Approach | PS/λ(nm) | Microorganisms | |
|---|---|---|---|---|
|
| Aurein 1.2 (AU1.2) peptide with 13 amino acid residues | |||
| Poly- | ||||
| ε-Polylysine acquired from a commercial department | ||||
LEGEND—BOHTMPn: 2,7,12,17-tetrakis(2-methoxyethyl)-9-p-carboxybenzyloxyporphycene; GlamTMPn: 2,7,12,17-tetrakis(2-methoxyethyl)-9-glutaramidoporphycene; CPZ: mono-substituted β-carboxyphthalocyanine zinc(II); VRE: Vancomycin-Resistant Enterococci
Other approaches used to improve aPDT efficacy.
| Approach | Materials or Methodologies | PS/λ(nm) | Microorganism(s) | ||
|---|---|---|---|---|---|
|
|
|
| |||
|
| |||||
|
|
| ||||
|
|
|
| |||
|
|
| ||||
|
|
|
| |||
|
| 10% |
|
| ||
| 20% |
|
| |||
|
| |||||
| Potassium iodide ( |
| ||||
|
| |||||
| Potassium thiocyanate ( |
|
| |||
| Sodium azide ( | |||||
LEGEND—Chl-TPFPP: pyrrolidine-fused chlorin derivative chlorin-2; MPAP2+: 5,10-di(4-methylphenyl)-15,20-di(4-N,N,N-tri-methylammoniumphenyl) porphyrin; TPPS4−: 5,10,15,20-tetrakis(4-sulphonatophenyl) porphyrin; Zn(II)e6Me: Zn(II)chlorin e6 methyl ester; PEI-ce6: polyethylenimine and chlorin e6.
Sonodynamic therapy factors and individual features used to improve aPDT efficacy.
| Approach | Conditions | PS/λ(nm) | Microorganism(s) | |
|---|---|---|---|---|
|
| 28 kHz |
|
| |
| 28–36 kHz |
|
| ||
| Passive ultrasonic irrigation (PUI) | ||||
| 1 MHz |
| MRSA | ||
|
| ||||
LEGEND—Photodithazine (PDZ).